Cargando…

ANGPTL4 regulate glutamine metabolism and fatty acid oxidation in nonsmall cell lung cancer cells

Angiopoietin‐like protein (ANGPTL) 4 is a key factor in the regulation of lipid and glucose metabolism in metabolic diseases. ANGPTL4 is highly expressed in various cancers, but the regulation of energy metabolism in tumours remains to be determined. This study explored the role of ANGPTL4 in aerobi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Song, Nai‐dong, Wang, Jin‐Xiang, Yan, Long, Tian, Xiu‐Rong, Lu, Hong, Gao, Jie‐Cheng, Yan, Fei, Zhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980907/ https://www.ncbi.nlm.nih.gov/pubmed/35285130 http://dx.doi.org/10.1111/jcmm.16879

Ejemplares similares

Selective Depletion of Regulatory T Cell Subsets by Docetaxel Treatment in Patients with Nonsmall Cell Lung Cancer
por: Li, Jie-Yao, et al.
Publicado: (2014)

Effect of omega 3 fatty acids on C-reactive protein and interleukin-6 in patients with advanced nonsmall cell lung cancer
por: Lu, Yan, et al.
Publicado: (2018)

Pemetrexed-associated Ischemic Colitis in Nonsmall Cell Lung Cancer
por: Ye, Liang, et al.
Publicado: (2017)

Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017)

Modern therapies of nonsmall cell lung cancer
por: Jachowski, Andrzej, et al.
Publicado: (2023)

Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids
por: Chen, Yan Q., et al.
Publicado: (2020)

TP53 Mutations in Nonsmall Cell Lung Cancer
por: Mogi, Akira, et al.
Publicado: (2011)

Signatures of Drug Sensitivity in Nonsmall Cell Lung Cancer
por: Gong, Hua C., et al.
Publicado: (2011)

The Role of Proteasome Inhibition in Nonsmall Cell Lung Cancer
por: Escobar, Mauricio, et al.
Publicado: (2011)

Gemcitabine for the treatment of advanced nonsmall cell lung cancer
por: Toschi, Luca, et al.
Publicado: (2009)

Thyroid Metastasis from Nonsmall Cell Lung Cancer
por: Namad, Tariq, et al.
Publicado: (2013)

An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer
por: Zhao, Nan, et al.
Publicado: (2015)

Bronchoscopic treatment of inoperable nonsmall cell lung cancer
por: Kniese, Christopher M., et al.
Publicado: (2020)

First-Line Gemcitabine Plus Cisplatin in Nonsmall Cell Lung Cancer Patients
por: Li, Ying, et al.
Publicado: (2014)

Rational application of the first‐line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta‐analysis
por: Cao, Rui, et al.
Publicado: (2019)

Glutamine metabolism in cancers: Targeting the oxidative homeostasis
por: Gong, Tengfang, et al.
Publicado: (2022)

Impacts of lung and tumor volumes on lung dosimetry for nonsmall cell lung cancer
por: Lei, Weijie, et al.
Publicado: (2017)

Is major pathologic response sufficient to predict survival in resectable nonsmall‐cell lung cancer patients receiving neoadjuvant chemotherapy?
por: Cai, Jing‐Sheng, et al.
Publicado: (2021)

Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer
por: Zhang, Xiaojun, et al.
Publicado: (2017)

Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
por: Gomez, Daniel R., et al.
Publicado: (2012)

Radiofrequency Ablation for Early-Stage Nonsmall Cell Lung Cancer
por: Hiraki, Takao, et al.
Publicado: (2014)

Pattern of bone metastasis in patients with nonsmall cell lung cancer
por: Miyazaki, Kunihiko, et al.
Publicado: (2018)

Solitary fibular metastasis from nonsmall cell lung carcinoma
por: Akram, Mohammad, et al.
Publicado: (2017)

Interleukin-33 Involvement in Nonsmall Cell Lung Carcinomas: An Update
por: Casciaro, Marco, et al.
Publicado: (2019)

Disparate outcomes in nonsmall cell lung cancer by immigration status
por: Chau, Brittney, et al.
Publicado: (2021)

How to handle oligometastatic disease in nonsmall cell lung cancer
por: Eichhorn, Florian, et al.
Publicado: (2021)

Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
por: Crinò, Lucio, et al.
Publicado: (2014)

New developments in locally advanced nonsmall cell lung cancer
por: Huber, Rudolf M., et al.
Publicado: (2021)

Glutamine reliance in cell metabolism
por: Yoo, Hee Chan, et al.
Publicado: (2020)

A comprehensive bioinformatics analysis of FOXP3 in nonsmall cell lung cancer
por: Zhu, Jianfei, et al.
Publicado: (2022)

Molecular Imaging in Therapeutic Efficacy Assessment of Targeted Therapy for Nonsmall Cell Lung Cancer
por: Hu, Yanni, et al.
Publicado: (2012)

Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer
por: Miao, Jian-Long, et al.
Publicado: (2016)

Correlation of quantified metabolic activity in nonsmall cell lung cancer with tumor size and tumor pathological characteristics
por: Karam, Mehrdad Bakhshayesh, et al.
Publicado: (2018)

Id1 Promotes Tumor Cell Migration in Nonsmall Cell Lung Cancers
por: Bhattacharya, Raka, et al.
Publicado: (2010)

Clinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer
por: Kim, Gun-Jik, et al.
Publicado: (2017)

Tannic Acid Exhibits Antiangiogenesis Activity in Nonsmall-Cell Lung Cancer Cells
por: Hatami, Elham, et al.
Publicado: (2022)

Sertaconazole provokes proapoptotic autophagy via stabilizing TRADD in nonsmall cell lung cancer cells
por: Zhang, Wenhui, et al.
Publicado: (2021)

The role of ANGPTL3 in controlling lipoprotein metabolism
por: Tikka, Anna, et al.
Publicado: (2016)

ANGPTL8: An Important Regulator in Metabolic Disorders
por: Luo, Mengdie, et al.
Publicado: (2018)

Proteasome inhibitors in the treatment of nonsmall cell lung cancer: A systematic review of clinical evidence
por: Chua, Alethea Dasha Wenning, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bmt4lkqhnvmvueb0qmngs1eede